Dexamethasone Prior to Re-treatment With Enzalutamide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Enzalutamide and Docetaxel

Clinical trial NCT02491411 · TERMINATED

Trial details

NCT number: NCT02491411
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Hormone-Resistant Prostate Cancer Metastatic Prostate Carcinoma Prostate Adenocarcinoma Stage IV Prostate Cancer

Start date: 2015-09-01
Primary completion: 2018-03-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.